HIV Drug Resistance Testing Costing Tool
This tool was developed to support national HIV programs and ministries of health to estimate and compare the cost of the following two...
top of page
A framework to support new product introduction in national health systems
Resource Library
- May 10, 2022
CHAI ARV Benchmark Price Comparison List
Last update: 2022 Q2 Within the ARV market, there are a number of reference price lists to help inform the latest costs of adult and...
357
- Sep 27, 2021
USAID Global Health Supply Chain Program Product e-Catalog
GHSC-PSM strategically sources and manages quality-assured commodities like essential medicines and supplies for HIV/AIDS, malaria,...
131
- Sep 21, 2021
ALSM Diagnostic Pricing Database
Low- and middle-income countries (LMIC) currently experience low testing coverage in the face of increasing demand to meet the needs of...
60
- Aug 16, 2021
Pediatric DTG Introduction: Transition Plan Templates
Fillable report and presentation template for governments to adjust as needed for introduction of pediatric DTG. English | French
82
- Jul 20, 2021
Transitioning to the 2021 WHO optimal formulary for antiretroviral drugs for children
This policy brief outlines key considerations to facilitate effective transition to more clinically appropriate regimens as optimal...
25
- Mar 2, 2021
PEPFAR Country Operational Plan Process
Given their role in funding and procuring commodities, it is important to align product introduction plans with donor budgetary processes...
27
- Jan 6, 2021
MSF Untangling the Web of ARV Price Reductions
For more than 20 years, the MSF Access Campaign has been monitoring the patent barriers, prices and availability of antiretroviral...
58
- Jan 1, 2021
The Global Fund Pooled Procurement Mechanism ARV Reference Pricing
The Global Fund has established framework agreements with manufacturers of antiretroviral medicines with the aim to achieve lower prices...
234
- May 28, 2020
Leveraging ARV Optimization Opportunities to Unlock National Cost Savings
This memo highlights the benefits, market considerations, and potential for savings of three ARV optimization opportunities. Proactively...
2
- Jun 5, 2018
HIV Point-of-Care Diagnostics Toolkit
This Toolkit contains various practical tools and guidance to support countries as they introduce point-of-care (POC) HIV technologies...
24
- Dec 1, 2017
CHAI ARV Phase-In / Phase-Out Tool
As national programs introduce new, generic ARVs they must plan how and when the new product will be phased-in to ensure smooth and...
24
- Nov 8, 2017
CHAI Memo: Optimizing ARV Formularies Through Planned Product Substitutions
This memo outlines some of the challenges and benefits of ARV optimization, highlighting product transition successes through...
22
- Jul 23, 2016
Best Practices for New Product Introduction
This presentation from the 2016 International AIDS Society Conference outlines key approaches to product introduction, including working...
2
bottom of page